5 results
To investigate the long-term safety, tolerability and acceptability of Nasalfent in the treatment BTCP
The primary objective of this study is to establish the effects of a single bolus EPO administered just before a primary PCI for a first acute myocardial infarction, on left ventricular ejection fraction after 6 weeks, measured with planar…
Primary objective:• To evaluate the efficacy of luspatercept on RBC transfusion independence (RBC-TI for 12 weeks [84 days] with an associated concurrent mean hemoglobin increase >= 1.5 g/dL) compared with epoetin alfa for the treatment of…
Co-primary (tested in parallel for non-inferiority):- To compare daprodustat to rhEPO for CV safety (non-inferiority)- To compare daprodustat to rhEPO for Hgb efficacy(non-inferiority)
1. find out the true time-in-AF per AF category and identify progression of AF,2. uncover genetic predisposing patterns for AF and AF progression,3. find out electrical basis of AF,4. investigate the relationship between genetic changes, electrical…